Darae Ko, MD, MSc

Adjunct Assistant Professor, Boston University Chobanian & Avedisian School of Medicine

Publications

  • Published 2/1/2026

    Li B, Gershengorn HB, Vail EA, Wunsch H, Walkey AJ, Law AC, Ko D, Ayalon N, Kearney CM, Bosch NA. Inotrope selection in mixed cardiogenic shock with sepsis: a comparative analysis between milrinone and dobutamine. Ann Am Thorac Soc. 2026 Feb 01; 23(2):252-260. PMID: 40960311.

    Read at: PubMed

  • Published 1/1/2026

    Park CM, Thanapluetiwong S, Chen X, Oh G, Ko D, Kim DH. Sodium-Glucose Cotransporter 2 Inhibitors, Glucagon-Like Peptide 1 Receptor Agonists, and Frailty Progression in Older Adults With Type 2 Diabetes. Diabetes Care. 2026 Jan 01; 49(1):147-151. PMID: 41232081.

    Read at: PubMed

  • Published 12/29/2025

    Parks AL, Lykken JM, Rieu-Werden ML, Ko D, Kim DH, Fang MC, Greenberg SM, Witt DM, Supiano MA, Shah SJ. Risk of New Indications for Anticoagulants and Thrombolytics in People With Cognitive Impairment: Implications for Anti-Amyloid Therapy. Neurology. 2026 Jan 27; 106(2):e214489. PMID: 41461060.

    Read at: PubMed

  • Published 11/18/2025

    Lo SW, Ko D, Kim DH, Ngo LH, Singer DE, Shah SJ. Apixaban Benefit in Subclinical Atrial Fibrillation Accounting for Competing Risks: A Reanalysis of the ARTESIA Trial. medRxiv. 2025 Nov 18. PMID: 41040706.

    Read at: PubMed

  • Published 10/23/2025

    Evans PT, Chen X, Shah S, Kim DH, Ko D. Post-Stroke Atrial Fibrillation Detection With Insertable Cardiac Monitors in Patients With Dementia and Frailty. J Am Geriatr Soc. 2026 Feb; 74(2):589-592. PMID: 41131694.

    Read at: PubMed

Education

  • Columbia University College of Physicians and Surgeons, MD
  • Boston University School of Public Health, MSc
  • Bryn Mawr College, AB